SMTL ID : 3lon.2 (2 other biounits)

HCV NS3-4a protease domain with ketoamide inhibitor narlaprevir

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

hetero-1-1-mer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 4 residues within 4Å: Chain A: C.108, T.109, C.110, C.156 4 PLIP interactions: 3 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:C.108, A:C.110, A:C.156, H2O.1

1 x NNA: (1R,2S,5S)-3-[N-({1-[(tert-butylsulfonyl)methyl]cyclohexyl}carbamoyl)-3-methyl-L-valyl]-N-{(1S)-1-[(1R)-2-(cyclopropylamino)-1-hydroxy-2-oxoethyl]pentyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide(Covalent)

NNA.2: 17 residues within 4Å: Chain A: Q.52, T.53, H.68, R.134, I.143, L.146, K.147, G.148, S.149, S.150, F.165, R.166, A.167, A.168, V.169, C.170, D.179 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:Q.52, A:I.143, A:L.146, A:K.147, A:F.165, A:A.168, A:V.169, A:D.179 Hydrogen bonds: A:Q.52, A:G.148, A:S.150, A:R.166, A:A.168, A:A.168, A:A.168

1 x BME: BETA-MERCAPTOETHANOL(Non-functional Binders)

BME.3: 5 residues within 4Å: Chain A: L.24, C.27, I.28, T.49, A.50 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Arasappan, A. et al., Candidate selection and preclinical evaluation culminating in the discovery of Narlaprevir (SCH 900518): A potent, selective and orally efficacious second generation HCV NS3 serine protease inhibitor. To be Published

Release Date

2011-01-19

Peptides

Genome polyprotein: A
KK-NS4a(21-39)-KK: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Genome polyprotein

KK-NS4a(21-39)-KK

Related Entries With Identical Sequence